ALLEGAN — Perrigo Co. (Nasdaq: PRGO) announced that it has entered into Cooperation and License agreements with Brilite Nutritionals (Shanghai) Co., Ltd. (“Brilite”), a Shanghai based infant nutrition company. Under these agreements, Perrigo will supply its Bright Beginnings infant formula brand to Brilite, which will exclusively source all its infant formula requirements from Perrigo’s U.S. manufacturing facilities, for sale and distribution in Greater China. Shipping begins immediately.
Perrigo Chairman and CEO Joseph C. Papa stated, “This is the second agreement for premium infant formula distribution in China that Perrigo has signed in the last few weeks with more agreements to come soon. Infant formula is a new category for Brilite and we are proud to be their exclusive supplier. Brilite’s proven executive team, innovative marketing, and retail distribution capabilities, will enhance the growth of our established brand.”
Charlie Li, Spokesperson for Brilite Nutritionals added, “We are thrilled about this partnership with Perrigo and are confident that, together, we will build Bright Beginnings into one of the leading premium infant formula brands in the Greater China markets.”
Perrigo develops, manufactures and distributes over-the-counter and generic prescription pharmaceuticals, infant formulas, nutritional products, and active pharmaceutical ingredients. The company is the world’s largest manufacturer of OTC pharmaceutical products and infant formulas, both for the store brand market. The company’s primary markets and locations of manufacturing and logistics operations are the United States, Israel, Mexico, the United Kingdom and Australia.
More at www.perrigo.com.